Medical researchers are making unprecedented progress into understanding why women suffer disproportionately from a number of diseases. Those insights are providing information to help develop medicines to attack diseases such as osteoporosis, multiple sclerosis, depression, rheumatoid arthritis and age-related macular degeneration, all of which affect more women than men.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/50270/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
With Arizona facing its share of tragedies lately – economically, politically and most recently the wildfires which have impacted thousands of residents – the community has found comfort in rallying together to celebrate the grand opening of the new Phoenix Children’s Hospital. The campus of Arizona’s only hospital 100 percent for children grew from 345 licensed beds to 465, and will ultimately house 626 licensed beds at full build-out, expected in 2013.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phoenixchildrenshospital/50358/
Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the HomeLox portable liquid oxygen system. The innovative system enables oxygen users to generate and store the liquid form of oxygen in the home setting. The HomeLox system offers users the long-lasting and lightweight characteristics of traditional liquid systems, while freeing them from difficulties of filling and dependence on deliveries associated with conventional systems.
Home oxygen is a critical, life-sustaining medical treatment prescribed to nearly 1.5 million Medicare patients annually who suffer from respiratory illnesses such as chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/philips/45648/
Delivering a healthy dose of good news to Midwest families, Meijer announced today that its free pre-natal vitamins prescription program has filled its 1,000,000th prescription, at a cost savings of nearly $14 million to Midwest families.
The announcement, made by Hank Meijer, Co-Chairman and CEO, came as the Midwest retailer reported that its pharmacies had hit the million-mark milestone earlier this week.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/meijer/50770/
Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer (mCRPC).
To view Multimedia News Release, go to http://www.multivu.com/mnr/50924-dendreon-provenge-cellular-immunotherapy
Bad dietary habits and modern sedentary lifestyles have converged to create a worldwide epidemic that is constantly increasing: obesity (BMI > 30).
One billion adults around the world and twenty-two million children under the age of 5 are overweight.
Faced with this problem, LPG wanted to study the effect of LPG® mechano stimulation on fat cells to obtain proven results of the impact of Cellu M6® on localised areas of fat.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/lpg/50526/
Sermo, Inc. (www.sermo.com), the largest online network in the United States exclusive to physicians, today introduced Sermo Mobile, an application that allows physicians to access the country’s greatest concentration of medical knowledge in real-time. Sermo Mobile builds on Sermo’s current web platform, an online resource where physicians from across 68 specialties and all 50 states collaborate, discuss and consult with each other to provide the highest quality care to their patients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51104-sermo-launches-real-time-medicine-mobile-app-for-physicians
A new national survey shows most preteens and teens engage in day-to-day activities that may put them at risk of contracting meningococcal meningitis, a rare, but serious bacterial infection that can cause meningitis and take the life of an otherwise healthy child in just a single day. The National Association of School Nurses (NASN), in collaboration with Sanofi Pasteur, conducted the survey as part of its Voices of Meningitis back-to-school vaccination awareness initiative.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/voicesofmeningitis/50125/
FedEx and ORBIS International, a leading global organization dedicated to saving sight worldwide, today kicked off a North American Goodwill Tour in Los Angeles, California with the announcement of a new $5.375 million commitment in the form of cash and in-kind gifts from FedEx. In addition, FedEx will donate an MD-10-30 cargo aircraft to ORBIS to be the third-generation Flying Eye Hospital. The Flying Eye Hospital will also visit Burlington, VT, Dallas/Fort Worth, TX, Memphis, TN, and Toronto and Ottawa, Canada between August and November to raise public awareness of the need to eliminate avoidable blindness.
To view Multimedia News Relwase, go to http://multivu.prnewswire.com/mnr/orbis/45157/
Susan Lucci is no stranger to the spotlight and now she is talking about a serious issue that’s close to her heart – atrial fibrillation (AFib) and its connection to stroke. In a national public service announcement (PSA) recently launched, Lucci and her husband, Helmut Huber, who lives with AFib, are encouraging the more than 2.3 million Americans living with the condition, along with their loved ones, to join them in taking the Facing AFib Pledge to do all they can to reduce the risk of AFib-related stroke.
To view Multimedia News Release, go to http://www.multivu.com/players/English/49621-facing-afib/
Life is unpredictable and can be even more so when you have allergies. During this fall allergy season, your runny nose, sneezing or itchy, watery eyes just might earn you top honors in Allegra's new Allergy Adventures contest on Facebook. Allergy sufferers are invited to upload a short video showing their daily challenges with allergies for a chance to win $5,000 toward a fun-filled adventure where they can enjoy life – without worrying about allergies.
Over 40 million adults suffer from indoor and outdoor allergies in the United States. During the fall, many people suffer from allergy triggers such as ragweed and dust mites. The contest is meant to help people say farewell to disruptive allergy symptoms now that fast (starts working at hour one), long-lasting, non-drowsy relief is available over-the-counter from Allegra.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/allegra/50885/
